STMicroelectronics N.V. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on November 23, 2001, reports STMicroelectronics N.V.'s unaudited financial results for the third quarter and first nine months ended September 29, 2001. The semiconductor industry faced a severe downturn, with worldwide sales declining approximately 28% year-over-year for the nine-month period. STMicroelectronics reported a 31.4% revenue decline for the third quarter compared to the same period in 2000, driven by reduced sales volumes and pricing pressure.
Key Financial Metrics
| Metric (in millions USD) | Q3 2001 | Q3 2000 | 9M 2001 | 9M 2000 |
|---|---|---|---|---|
| Net Revenues | $1,400.7 | $2,042.0 | $4,909.0 | $5,621.5 |
| Gross Profit | $462.1 | $964.9 | $1,850.4 | $2,557.7 |
| Gross Margin | 33.0% | 47.3% | 37.7% | 45.5% |
| Operating Income | $48.2 | $511.8 | $268.6 | $1,219.5 |
| Net Income | $35.8 | $415.3 | $212.1 | $990.2 |
| Diluted EPS | $0.04 | $0.45 | $0.23 | $1.08 |
| Cash & Equivalents | $1,210.0 | N/A | N/A | N/A |
| Marketable Securities | $1,135.6 | N/A | N/A | N/A |
| Total Debt (Long-term + Current) | $2,898.5 | N/A | N/A | N/A |
Liquidity: As of September 29, 2001, the company held $2,345.6 million in cash, cash equivalents, and marketable securities. Net cash provided by operating activities for the nine months ended September 29, 2001, was $1,580.3 million.
Material Changes vs. Prior Period
- Revenue Decline: Net revenues dropped 31.4% in Q3 2001 and 12.7% for the nine-month period compared to 2000. The Consumer & Microcontrollers segment saw the steepest decline at 46.6% in Q3.
- Margin Compression: Gross margin fell from 47.3% to 33.0% in Q3 due to under-utilization of wafer fabs and price declines.
- Restructuring Charges: The company recorded $23.3 million in impairment and restructuring charges in Q3 2001 related to the closure of the Rancho Bernardo, California, 150 mm plant. A larger charge of $311.3 million was recorded in Q2 2001.
- Inventory Charges: A special excess inventory charge of $70.7 million was recorded in Q2 2001 due to order cancellations and push-outs.
- Cost Reductions: Selling, general, and administrative (SG&A) expenses decreased 17.1% in Q3 2001 due to hiring freezes and cost control programs.
Guidance, Outlook, and Risks
Outlook: Management expects fourth-quarter 2001 revenues and gross margins to approximate third-quarter 2001 levels. The company cited global economic and political uncertainty as making precise guidance difficult.
Strategic Actions:
- Plant Closures: The company is closing mature 150 mm fabrication facilities, including Ottawa (announced May 2001) and Rancho Bernardo (announced Q3 2001), to reduce costs and improve utilization.
- Share Repurchases: In September 2001, the company announced a plan to repurchase up to 5 million shares. By November 2001, it completed an additional repurchase of 4.4 million shares for $127.4 million to fund employee stock options.
- Joint Venture: Formed SuperH, Inc. with Hitachi Ltd. in Q3 2001 to develop RISC microprocessors.
Risks: Key risks include the cyclicality of the semiconductor industry, excess inventory, currency fluctuations (specifically the U.S. dollar vs. Euro), and the potential unavailability of financing for capital requirements.
Investor Verification Checklist
- Restructuring Costs: Verify the total expected costs for the Rancho Bernardo closure, including future severance and relocation expenses not yet accrued.
- Inventory Levels: Assess the risk of further inventory write-downs given the $70.7 million charge in Q2 and the industry-wide trend of order cancellations.
- Capital Expenditures: Confirm the company's ability to fund the projected $1.8 billion in capital spending for 2001 amidst reduced operating cash flow.
- FX Exposure: Monitor the impact of the U.S. dollar's strength against the Euro on future cost of sales and revenue translation.
- Pro Forma Performance: Review pro forma earnings (excluding one-time charges) which showed a Q3 operating income of $71.5 million, to gauge underlying operational health.